T1	Participants 47 139	previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642
T2	Participants 1232 1491	Patients had to have histologically documented measurable breast cancer and a performance status of 0-1. Patients could not have had prior chemotherapy for metastatic disease. Prior adjuvant chemotherapy was permitted. Patients could not have visceral crisis.
